Sachs U J, Kiefel V, Böhringer M, Afshar-Kharghan V, Kroll H, Santoso S
Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig-University, Giessen, Germany.
Blood. 2000 Mar 1;95(5):1849-55.
We recently described a new low-frequency platelet alloantigen on the human platelet glycoprotein (GP) Ib-IX complex, termed Iy(a), which was implicated in a severe case of neonatal alloimmune thrombocytopenia. Immunoprecipitation studies with trypsin-treated platelets indicated that the Iy(a) alloantigenic determinants are formed by the membrane-associated remnant moiety of GP Ibalpha (GP Ibalpha(r)) together with GP Ibbeta and GP IX. To elucidate the molecular basis underlying the Iy(a) alloantigen, we amplified GPIbalpha(r), GPIbbeta, and GPIX genes by polymerase chain reaction (PCR). Nucleotide-sequence analysis of these 3 genes showed a G to A transition at position 141 on GPIbbeta gene in a subject positive for Iy(a). This transition resulted in a Gly(15)Glu dimorphism on the N-terminal domain of GPIbbeta. This finding was confirmed by genotyping analysis of 6 Iy(a)-positive subjects by restriction fragment length polymorphism (RFLP) studies using NarI endonuclease. In 300 randomly selected healthy blood donors, one Iy(a)-positive individual was found. Phenotypes determined by monoclonal antibody-specific immobilization of platelet antigens assay and genotypes determined by RFLP were identical in this population. Analysis of Iy(a)-positive platelets showed that the point mutation affected neither the degree of surface expression nor the function of the GP Ibalpha-GP Ibbeta-IX complex on the platelet surface. Transient expression of the GP Ib-IX complex in CHO cells using wild-type GP Ibbeta (Gly(15)) or mutant GP Ibbeta (Glu(15)) allowed us to demonstrate that this single amino acid substitution is sufficient to induce Iy(a) epitope(s). (Blood. 2000;95:1849-1855)
我们最近在人血小板糖蛋白(GP)Ib-IX复合物上描述了一种新的低频血小板同种抗原,称为Iy(a),它与一例严重的新生儿同种免疫免疫性免疫性血小板减少症有关。用胰蛋白酶处理血小板的免疫沉淀研究表明,Iy(a)同种抗原决定簇是由GP Ibalpha(GP Ibalpha(r))的膜相关残余部分与GP Ibbeta和GP IX共同形成的。为了阐明Iy(a)同种抗原的分子基础,我们通过聚合酶链反应(PCR)扩增了GPIbalpha(r)、GPIbbeta和GPIX基因。对这3个基因的核苷酸序列分析显示,在一名Iy(a)阳性受试者中,GPIbbeta基因第141位发生了G到A的转变。这种转变导致GPIbbeta N端结构域出现Gly(15)Glu二态性。通过使用NarI核酸内切酶的限制性片段长度多态性(RFLP)研究对6名Iy(a)阳性受试者进行基因分型分析,证实了这一发现。在300名随机选择的健康献血者中,发现了一名Iy(a)阳性个体。在该人群中,通过单克隆抗体特异性固定血小板抗原试验确定的表型与通过RFLP确定的基因型相同。对Iy(a)阳性血小板的分析表明,该点突变既不影响血小板表面GP Ibalpha-GP Ibbeta-IX复合物的表面表达程度,也不影响其功能。使用野生型GPIbbeta(Gly(15))或突变型GPIbbeta(Glu(15))在CHO细胞中瞬时表达GP Ib-IX复合物,使我们能够证明这种单一氨基酸取代足以诱导Iy(a)表位。(《血液》。2000年;95:1849-1855)